Dementia Therapies and Interventions

Activity Details
  • Credit Amounts:
    • TSBSWE: 0.75
    • UNTHSC: 0.75
    • Counselor: 0.75
    • TNA: 0.75
  • Cost: Free
  • Release: Dec 12, 2017
  • Expires: Dec 12, 2019
  • Estimated Time to Complete:
    45 Minutes
  • System Requirements:
  • Average User Rating:
    (4 Ratings)

Faculty

 This activity has 7 faculty members associated with it.
Click Here to View All
Joseph F.  Berck Joseph F. Berck, MBA, LVN, LMFA, CDP
Healthcare Administrator
James L. West Alzheimer's Center
Fort Worth, Texas

Shara Elrod Shara Elrod, PharmD, BCACP
Director of Community and Ambulatory Practice
Assistant Professor of Pharmacotherapy
UNT System College of Pharmacy
Fort Worth, Texas

Susan Farris Susan Farris, FACHCA, LNFA
President & Executive Director
James L. West Alzheimer's Center
Fort Worth, Texas

James R.  Hall James R. Hall, PhD, FABMP
Professor
Department of Psychiatry & Behavior Health
UNT Health Science Center
Fort Worth, Texas

Barbara  L.  Harty Barbara L. Harty, RN, MSN, GNP
Assistant Professor
Department of Geriatrics
UNT Health Science Center
Fort Worth, Texas

Linda C.  Mayfield Linda C. Mayfield, LVN
Assistant Director of Nursing
James L. West Alzheimer's Center
Fort Worth, Texas

Laura McEntire Laura McEntire, LCSW, ACSW
Manager of Family Care Services
Alzheimer's Association
Fort Worth, Texas

Needs Statement

Studies have found that more than 90% of people with dementia will experience behavioral and psychotic symptoms during the course of their disease progression. Due to a lack of FDA approved drug treatments for behavioral and psychotic symptoms, atypical antipsychotics have been the first line of treatment for many years. Evidence shows that antipsychotics have limited effectiveness and increase the risk for mortality and cerebrovascular events among users with dementia. Substantial evidence shows that nonpharmacological approaches can yield high levels of patient and caregiver satisfaction, quality of life improvements, and reductions in behavioral symptoms. This video addresses the appropriate use of medication in dementia care and discusses best practices in nonpharmacologic therapies and implementation in standard dementia care.

This program is the second in a three part series that will address deficiencies in healthcare professional knowledge/competence related to Alzheimer’s disease, dementia and the role of the Healthcare Professional.

Target Audience

Interdisciplinary healthcare professionals, RN, LVN, LNFA, SW, LPC, and Home Health Caregivers in three types of care settings: facility-based staff, home health caregivers, and primary care physician office staff.

Objectives

  • Explain the use and efficacy of the FDA approved Alzheimer’s disease medications;
  • Discuss and evaluate the appropriate use and efficacy for off-label and antipsychotic medications in treating Alzheimer’s disease and related dementias;
  • Evaluate best practices in nonpharmacological therapies for individuals with Alzheimer’s disease and related dementias;
  • Assess and discuss best practices for implementing culture change in long-term care settings and making it a part of standard dementia care; and 
  • Identify at least three community resources. 

Accreditation

TNA
UNT Health Science Center is an approved provider of continuing nursing education by the Texas Nurses Association - Approver, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

This activity provides up to 0.75 contact hours.

TSBSWE
This activity is approved for a maximum of 0.75 Clock Hours for Social Workers.

Counselor
Texas LPC CEU

University of North Texas Health Science Center is an approved provider, number 2022, by the Texas State Board of Examiners of Professional Counselors. This activity is approved for 0.75 CEU credits/0.75 clock hours.

Faculty Disclosure

Joey Berck has nothing to disclose.
Shara Elrod has nothing to disclose.
Susan Farris has nothing to disclose.
James Hall has nothing to disclose.
Barbara Harty has nothing to disclose.
Linda Mayfield has nothing to disclose.
Laura McEntire has nothing to disclose.

Acknowledgment

WE-HAIL LogoThis project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U1QHP287350100. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Health Resources and Services Administration or the U.S. Department of Health and Human Services.

No commercial support was received for this activity.

Nursing Professional Practice Gap

The content of this activity will close the knowledge gap that some nurses who do not specifically work with dementia patients may face.  This activity addresses how the appropriate use of antipsychotic medications in patients with dementia can yield high levels of patient and caregiver satisfaction, quality of life improvements, and reductions in behavioral symptoms.